National HealthCare Corp.

As of October 3, 2025, National HealthCare Corp. shows a bullish technical trend supported by positive MACD and moving averages, despite mixed signals from Bollinger Bands and KST, while underperforming the S&P 500 recently but outperforming it over the past month and three years.

As of October 3, 2025, National HealthCare Corp. shows a bullish technical trend supported by positive MACD and moving averages, despite mixed signals from Bollinger Bands and KST, while underperforming the S&P 500 recently but outperforming it over the past month and three years.

As of October 3, 2025, National HealthCare Corp. shows a bullish technical trend supported by positive MACD and moving averages, despite mixed signals from KST and OBV, while underperforming the S&P 500 over the past week and year but outperforming it over the past month and three years.

As of September 26, 2025, National HealthCare Corp. shows a mildly bullish technical trend, supported by strong weekly indicators, despite mixed monthly signals and underperformance over the past year compared to the S&P 500.

As of September 26, 2025, National HealthCare Corp. shows a mildly bullish technical trend with strong weekly indicators, mixed monthly signals, and has outperformed the S&P 500 in the short term, but lags behind in the one-year return.

As of September 11, 2025, National HealthCare Corp. shows a bullish trend supported by positive weekly MACD and Bollinger Bands, although caution is advised due to mildly bearish monthly indicators, and while it has outperformed the S&P 500 recently, it has lagged over longer periods.

As of August 5, 2025, National HealthCare Corp. is fairly valued with a P/E ratio of 16, lower than the industry average of 18.51, and despite strong growth potential indicated by a PEG ratio of 0.34, it has underperformed the S&P 500 with a return of -3.46% over the past year.

As of February 27, 2025, National HealthCare Corp. is fairly valued with a P/E ratio of 16 and an EV to EBITDA of 8.72, outperforming the S&P 500 with a 4.01% return, while its peers show riskier valuations.

As of May 19, 2025, National HealthCare Corp. shows a mildly bearish trend, with mixed signals from various indicators, including bearish daily moving averages and bullish weekly Bollinger Bands.

As of March 2022, the management team of National HealthCare Corp. includes Non-Executive Chairman Mr. Robert Adams, CEO Dr. Stephen Flatt, Directors Mr. W. Andrew Adams, Dr. J. Paul Abernathy, Mr. Ernest Burgess, and Independent Director Mr. Emil Hassan. They oversee the company's operations and strategic direction.

National HealthCare Corporation (NHC) operates in the post-acute healthcare sector, offering skilled nursing, assisted living, independent living, and homecare services. As of March 2025, it reported net sales of $372 million and a net profit of $32 million, with a market cap of approximately $1.58 billion.

As of Jun 18, National HealthCare Corp. has a market capitalization of 1,575.57 million and reported net sales of 1,363.30 million with a net profit of 108.13 million over the latest four quarters.